Back to Results

PHANTOM: Anastrozole in Patients with Pulmonary Arterial Hypertension

Study category: Heart and Blood Conditions

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

Men and women over 18 years of age Must have been diagnosed with pulmonary hypertension by a right heart catheterization Must have PAH which is idiopathic, heritable, drug or toxin induced, associated with connective tissue disease, congenital heart disease, portal hypertension or HIV and receiving treatment for PAH Cannot be pregnant, of child bearing potential or on any hormone replacement therapy Must be able to preform a 6 min walk test Must not have a history of Breast Cancer Must not have untreated obstructive sleep apnea

Phase

II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Todd Bull,  MD

Todd Bull, MD

Study ID

Protocol Number: 17-0536

ClinicalTrials.gov: NCT03229499

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers